G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.4 SEK 32% Market Closed
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Cash from Operating Activities Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Cash from Operating Activities
kr37.3m
CAGR 3-Years
73%
CAGR 5-Years
60%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Cash from Operating Activities
kr773m
CAGR 3-Years
-7%
CAGR 5-Years
34%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash from Operating Activities
kr178.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cash from Operating Activities
kr364m
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
18%
MedCap AB (publ)
STO:MCAP
Cash from Operating Activities
kr299.1m
CAGR 3-Years
49%
CAGR 5-Years
23%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash from Operating Activities
kr15.3m
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Cash from Operating Activities?
Cash from Operating Activities
37.3m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Cash from Operating Activities amounts to 37.3m SEK.

What is Genovis AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
60%

Over the last year, the Cash from Operating Activities growth was -24%. The average annual Cash from Operating Activities growth rates for Genovis AB have been 73% over the past three years , 60% over the past five years .

Back to Top